(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.45%) $79.62
(0.30%) $2.31
(0.55%) $2 353.10
(0.72%) $28.57
(0.22%) $993.00
(-0.30%) $0.927
(-0.37%) $10.85
(-0.24%) $0.798
(0.90%) $92.56
5 days till quarter result
(bmo 2024-05-14)
Expected move: +/- 13.86%
-1.86% $ 0.485
@ $0.800
Wydano: 7 vas. 2024 @ 20:05
Zwrot: -39.34%
Poprzedni sygnał: vas. 7 - 18:44
Poprzedni sygnał:
Zwrot: -5.88 %
Live Chart Being Loaded With Signals
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 55 918.00 |
Średni wolumen | 248 067 |
Kapitalizacja rynkowa | 12.74M |
EPS | $0 ( 2024-05-07 ) |
Następna data zysków | ( $0.620 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.180 |
ATR14 | $0.00500 (1.03%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-29 | Tosca Melissa | Buy | 60 000 | Stock Option (right to buy) |
2023-09-29 | Tosca Melissa | Buy | 30 000 | Common Stock |
2023-09-29 | Daniels Eric Joseph | Buy | 125 000 | Stock Option (right to buy) |
2023-09-29 | Daniels Eric Joseph | Buy | 62 500 | Common Stock |
2023-09-29 | Strem Brian M. | Buy | 150 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 91 transactions |
Buy: 1 933 640 | Sell: 3 426 001 |
Wolumen Korelacja
Kiora Pharmaceuticals, Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kiora Pharmaceuticals, Korelacja - Waluta/Towar
Kiora Pharmaceuticals, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-62 424.00 (0.00 %) |
EPS: | $-2.58 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-62 424.00 (0.00 %) |
EPS: | $-2.58 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-134 028 (0.00 %) |
EPS: | $-18.55 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-143.31 |
Financial Reports:
No articles found.
Kiora Pharmaceuticals,
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patients undergoing PRK surgery for corneal wound repair after refractive surgery. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej